The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Basic local alignment search tool

Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432

Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation

Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361

Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases

Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,331

Genetics of Parkinson's disease

Mizuno, Y., Hattori, N., & Mori, H. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80075-4 · Cited by 38

T cells, α-synuclein and Parkinson disease

Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 39

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease

Covy, J. P., & Giasson, B. I. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.01.003 · Cited by 38

Adsorption of α-Synuclein on Lipid Bilayers: Modulating the Structure and Stability of Protein Assemblies

Haque, F., Pandey, A. P., Cambrea, L. R., Rochet, J., & Hovis, J. S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1006704 · Cited by 37

Alpha‐Synuclein Modulates the Physical Properties of DNA

Jiang, K., Rocha, S., Westling, A., Sriram, K. K., Dorfman, K. D., Wittung-Stafshede, P. E., & Westerlund, F. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201803933 · Cited by 37

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis

Butkovich, L. M., Houser, M. C., & Tansey, M. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00626 · Cited by 39

Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4

Juul‐Madsen, K., Qvist, P., Bendtsen, K. L., Langkilde, A. E., Vestergaard, B., Howard, K. A., Dehesa-Etxebeste, M., Paludan, S. R., Andersen, G. R., Jensen, P. H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900494 · Cited by 37

In Vivo Alterations in Calcium Buffering Capacity in Transgenic Mouse Model of Synucleinopathy

Reznichenko, L., Cheng, Q., Nizar, K., Gratiy, S. L., Saisan, P. A., Rockenstein, E. M., Gonzalez, T., Patrick, C., Spencer, B. J., Desplats, P., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1270-12.2012 · Cited by 37

Distinct Hydration Properties of Wild-Type and Familial Point Mutant A53T of α-Synuclein Associated with Parkinson's Disease

Házy, E., Bokor, M., Kalmár, L., Gelencser, A., Kamasa, P., Han, K., Tompa, K., & Tompa, P. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.08.052 · Cited by 37

Investigation of the effects of copper ions on protein aggregation using a model system

Capanni, C., Luigi Messori, A., Orioli, P., Chiti, F., Stefani, M., Ramponi, G., Taddei, N., & Gabrielli, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3447-3 · Cited by 40

p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells

Pozzo, E. D., Pietra, V. L., Cosimelli, B., Settimo, F. D., Giacomelli, C., Marinelli, L., Martini, C., Novellino, E., Taliani, S., & Greco, G. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn4002208 · Cited by 38

A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research

Baptista, M. A. S., Dave, K. D., Sheth, N. P., Silva, S. N. D., Carlson, K. M., Aziz, Y. N., Fiske, B. K., Sherer, T., & Frasier, M. A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011940 · Cited by 37

Regulation of α-Synuclein Expression in Limbic and Motor Brain Regions of Morphine-Treated Mice

Ziółkowska, B., Gieryk, A., Bilecki, W., Wawrzczak‐Bargieła, A., Wędzony, K., Chocyk, A., Danielson, P. E., Thomas, E. A., Hilbush, B. S., Sutcliffe, J. G., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4376-04.2005 · Cited by 37

Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of α-synuclein in the presence of hydrogen peroxide

Kowalik‐Jankowska, T., Rajewska, A., Jankowska, E., Wiśniewska, K., & Grzonka, Z. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.05.010 · Cited by 37

The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease

Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 40

Structurally Distinct α‐Synuclein Fibrils Induce Robust Parkinsonian Pathology

Hayakawa, H., Nakatani, R., Ikenaka, K., Aguirre, C., Choong, C., Tsuda, H., Nagano, S., Koike, M., Ikeuchi, T., Hasegawa, M., et al. (2019) · Movement Disorders · doi:10.1002/mds.27887 · Cited by 33

Effect of Osmolytes on Conformational Behavior of Intrinsically Disordered Protein α-Synuclein

Jahan, I., & Nayeem, S. M. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.09.046 · Cited by 36

Multiple system atrophy (MSA): Topographic distribution of the α-synuclein-associated pathological changes

Armstrong, R. A., Cairns, N. J., & Lantos, P. L. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.02.005 · Cited by 36

Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease

Wakabayashi, K., Mori, F., & Takahashi, H. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.05.028 · Cited by 39

Brain prostaglandin formation is increased by α-synuclein gene-ablation during global ischemia

Golovko, M. Y., & Murphy, E. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.031 · Cited by 36

The Cell Biology of α Synuclein

Cole, N. B., & Murphy, D. D. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:2:95 · Cited by 35

Synelfin Regulation during the Critical Period for Song Learning in Normal and Isolated Juvenile Zebra Finches

Jin, H., & Clayton, D. F. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1997.3795 · Cited by 36

Hrs interacts with SNAP-25 and regulates Ca2+-dependent exocytosis

Kwong, J., Roudabush, F. L., Moore, P. H., Montague, M. G., Oldham, W. M., Li, Y., Chin, L., & Li, L. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2273 · Cited by 36

Synucleins Antagonize Endoplasmic Reticulum Function to Modulate Dopamine Transporter Trafficking

Oaks, A. W., Marsh‐Armstrong, N., Jones, J. M., Credle, J. J., & Sidhu, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070872 · Cited by 35

Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide

Choi, M., Kim, M. J., Kim, D.-G., Yu, R., Jang, Y.-N., & Oh, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195339 · Cited by 35

Interplay between Mitochondrial Protein Import and Respiratory Complexes Assembly in Neuronal Health and Degeneration

Needs, H. I., Protasoni, M., Henley, J. M., Prudent, J., Collinson, I. R., & Pereira, G. C. (2021) · Life · doi:10.3390/life11050432 · Cited by 32

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease

Nwabufo, C. K., & Aigbogun, O. P. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11267-9 · Cited by 37

Microtubule Depolymerization Suppresses α-Synuclein Accumulation in a Mouse Model of Multiple System Atrophy

Nakayama, K., Suzuki, Y., & Yazawa, I. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080503 · Cited by 35

Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy

Giasson, B. I., Mabon, M. E., Duda, J. E., Montine, T. J., Robertson, D., Hurtig, H. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0726-x · Cited by 35

Neuroprotection in PD—A role for dopamine agonists?

Schapira, A. H. V. (2003) · Neurology · doi:10.1212/wnl.61.6_suppl_3.s34 · Cited by 35

The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease

Battis, K., Xiang, W., & Winkler, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713270 · Cited by 38

Current insights and assumptions on α-synuclein in Lewy body disease

Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 41

Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases

Ortega, R. H., Cerezo, A. B., Troncoso, A. M., García-Parrilla, M. C., & Mas, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01565 · Cited by 34

A refined concept: α-synuclein dysregulation disease

Mochizuki, H., Choong, C., & Masliah, E. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.011 · Cited by 34

The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson’s Disease

Mariucci, G., Pagiotti, R., Galli, F., Romani, L. R., & Conte, C. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1057-7 · Cited by 34

Alpha-Synuclein RNA Expression is Increased in Major Depression

Rotter, A., Lenz, B., Pitsch, R., Richter‐Schmidinger, T., Kornhuber, J., & Rhein, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082029 · Cited by 33

Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies

Hass, E. W., Sorrentino, Z. A., Xia, Y., Lloyd, G. M., Trojanowski, J. Q., Prokop, S., & Giasson, B. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01242-2 · Cited by 34

Sequence and Membrane Determinants of the Random Coil–Helix Transition of α-Synuclein

Lokappa, S. B., Suk, J.-E., Balasubramanian, A., Samanta, S., Situ, A. J., & Ulmer, T. S. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.02.024 · Cited by 36

α-Synuclein Structures Probed by 5-Fluorotryptophan Fluorescence and 19F NMR Spectroscopy

Winkler, G. R., Harkins, S. B., Lee, J. C., & Gray, H. B. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp060043n · Cited by 34

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Kallhoff, V., Peethumnongsin, E., & Zheng, H. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-6 · Cited by 33

Autophagy in α-Synucleinopathies—An Overstrained System

Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 36

Recapitulation of zebrafish sncga expression pattern and labeling the habenular complex in transgenic zebrafish using green fluorescent protein reporter gene

Chen, Y., Cheng, C., Chen, G., Hung, C., Yang, C., Hwang, S. L., Kawakami, K., Wu, B.-K., & Huang, C. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21877 · Cited by 33

The 11‐mer repeats of human α‐synuclein in vesicle interactions and lipid composition discrimination: A cooperative role

Bisaglia, M., Schievano, E., Caporale, A., Peggion, E., & Mammi, S. (2006) · Biopolymers · doi:10.1002/bip.20440 · Cited by 33

Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture

Bell, K. C., Wilding, C., Funke, S., Perumal, N., Gehrke-Beck, S., Wolters, D., Holz‐Müller, J., Pfeiffer, N., & Grus, F. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13765 · Cited by 33

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles

Doucet, M., El-Turabi, A., Zabel, F., Hunn, B. H. M., Bengoa‐Vergniory, N., Cioroch, M., Ramm, M., Smith, A. M., Gomes, A. C., de Miranda, G. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181844 · Cited by 31

Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson’s Disease?

Zhang, Y., Zhang, X., Yue, Y., & Tian, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.799526 · Cited by 32

Visual signs and symptoms of dementia with Lewy bodies

Armstrong, R. A. (2012) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2012.00770.x · Cited by 32

Cross Dimerization of Amyloid-β and αSynuclein Proteins in Aqueous Environment: A Molecular Dynamics Simulations Study

Jose, J. C., Chatterjee, P., & Sengupta, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106883 · Cited by 32

Exogenous α-synuclein hinders synaptic communication in cultured cortical primary rat neurons

Hassink, G. C., Raiss, C. C., Segers‐Nolten, I. M. J., Wezel, R. J. A. V., Subramaniam, V., le Feber, J., & Claessens, M. M. A. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193763 · Cited by 33

Motor impairment and aberrant production of neurochemicals in human α-synuclein A30P+A53T transgenic mice with α-synuclein pathology

Ikeda, M., Kawarabayashi, T., Harigaya, Y., Sasaki, A., Yamada, S., Matsubara, E., Murakami, T., Tanaka, Y., Kurata, T., Wuhua, X., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.011 · Cited by 34

Interaction of Myocilin with γ-Synuclein Affects Its Secretion and Aggregation

Surgucheva, I. G., Park, B., Yue, B. Y. J. T., Tomarev, S. I., & Surguchov, A. P. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-8471-4 · Cited by 32

Alpha-Synuclein and Presynaptic Function: Implications for Parkinson's Disease

Lykkeboe, S., & Jensen, P. H. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:115 · Cited by 32

Serofendic acid prevents 6‐hydroxydopamine‐induced nigral neurodegeneration and drug‐induced rotational asymmetry in hemi‐parkinsonian rats

Inden, M., Kitamura, Y., Kondo, J., Hayashi, K., Yanagida, T., Takata, K., Tsuchiya, D., Yanagisawa, D., Nishimura, K., Taniguchi, T., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03413.x · Cited by 32

Genetic dissection of familial Parkinson's disease

Rieß, O., Jakes, R., & Krüger, R. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01343-4 · Cited by 32

Research Priorities on the Role of α‐ Synuclein in Parkinson's Disease Pathogenesis

Burré, J., Edwards, R. H., Halliday, G. M., Lang, A. E., Lashuel, H. A., Melki, R., Murayama, S., Outeiro, T. F., Papa, S. M., Stefanis, L., et al. (2024) · Movement Disorders · doi:10.1002/mds.29897 · Cited by 34

Parkinson's disease as a member of Prion-like disorders

Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 33

Neurodegenerative changes initiated by presynaptic dysfunction

Yasuda, T., Nakata, Y., Choong, C., & Mochizuki, H. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-16 · Cited by 31

Two‐Dimensional Crowding Uncovers a Hidden Conformation of α‐Synuclein

Banerjee, P. R., Moosa, M. M., & Deniz, A. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606963 · Cited by 31

Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…

Rouaud, T., Corbillé, A.-G., Leclair‐Visonneau, L., de Lataillade, A. D. G., Lionnet, A., Preterre, C., Damier, P., & Derkinderen, P. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.07.016 · Cited by 32

α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide

Hill, E., Gowers, R. P., Richardson, M. J. E., & Wall, M. J. (2020) · eNeuro · doi:10.1523/eneuro.0330-20.2020 · Cited by 31

Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy

Hass, E. W., Sorrentino, Z. A., Lloyd, G. M., McFarland, N. R., Prokop, S., & Giasson, B. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01173-y · Cited by 31

α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox

Simon, C. A., Soga, T., Okano, H. J., & Parhar, I. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00709-y · Cited by 35

Exploring the accessible conformations of N‐terminal acetylated α‐synuclein

Moriarty, G. M., Janowska, M. K., Kang, L., & Baum, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.049 · Cited by 32

Effect of metals on herbicides–α‐synuclein association: A possible factor in neurodegenerative disease studied by capillary electrophoresis

André, C., Truong, T. T., Robert, J. F., & Guillaume, Y. C. (2005) · Electrophoresis · doi:10.1002/elps.200500169 · Cited by 31

Alpha-synuclein: between synaptic function and dysfunction.

Rosa, G. D., Puzzo, D., Sant'Angelo, A., Trinchese, F., & Arancio, O. (2003) · PubMed · doi:10.14670/hh-18.1257 · Cited by 31

Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy

Rockenstein, E. M., Ubhi, K. K., Inglis, C. A., Mante, M., Patrick, C., Adame, A., & Masliah, E. (2012) · Neuroreport · doi:10.1097/wnr.0b013e3283509842 · Cited by 31

Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles

Kiškis, J., Horváth, I., Wittung-Stafshede, P. E., & Rocha, S. (2017) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583517000026 · Cited by 31

Interaction of LRRK2 and α-Synuclein in Parkinson’s Disease

Daher, J. P. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_11 · Cited by 30

Abundant fish protein inhibits α-synuclein amyloid formation

Werner, T., Kumar, R., Horváth, I., Scheers, N., & Wittung-Stafshede, P. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-23850-0 · Cited by 31

Neuronal microtubules and proteins linked to Parkinson’s disease: a relevant interaction?

Calogero, A. M., Mazzetti, S., Pezzoli, G., & Cappelletti, G. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0142 · Cited by 28

Genetics of synucleins in neurodegenerative diseases

Brás, J., Gibbons, E., & Guerreiro, R. J. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02202-1 · Cited by 30

Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties

Dent, S. E., King, D. P., Osterberg, V. R., Adams, E. K., Mackiewicz, M. R., Weissman, T. A., & Unni, V. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101552 · Cited by 34

Stabilization of α-synuclein oligomers using formaldehyde

Ruesink, H., Reimer, L., Gregersen, E., Moeller, A., Betzer, C., & Jensen, P. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216764 · Cited by 30

Recent Advances in Research on Parkinson Disease: Synuclein and Parkin

Burke, R. E. (2004) · The Neurologist · doi:10.1097/01.nrl.0000117822.90759.83 · Cited by 30

Eosin interaction of α-synuclein leading to protein self-oligomerization

Shin, H.-J., Lee, E., Lee, J., Lee, D., Chang, C., Kim, Y., & Paik, S. R. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00106-0 · Cited by 30

AβPeptide Originated from Platelets Promises New Strategy in Anti-Alzheimer’s Drug Development

Inyushin, M. Y., Sanabria, P., Rojas, L. V., Kucheryavykh, Y. V., & Kucheryavykh, L. Y. (2017) · BioMed Research International · doi:10.1155/2017/3948360 · Cited by 30

Roles for α-Synuclein in Gene Expression

Somayaji, M., Lanseur, Z., Choi, S. J., Sulzer, D., & Mosharov, E. V. (2021) · Genes · doi:10.3390/genes12081166 · Cited by 32

Current understandings and perspectives of petroleum hydrocarbons in Alzheimer’s disease and Parkinson’s disease: a global concern

Rajendran, R., Raghavan, R. P., Al-Sehemi, A. G., Uddin, M. S., Aleya, L., & Mathew, B. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17931-3 · Cited by 29

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas

Bhowmick, D. C., Kudaibergenova, Z., Burnett, L., & Jeremic, A. M. (2022) · Molecules · doi:10.3390/molecules27031021 · Cited by 30

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

Lloyd, G. M., Sorrentino, Z. A., Quintin, S. S., Gorion, K.-M. M., Bell, B. M., Paterno, G., Long, B., Prokop, S., & Giasson, B. I. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02425-4 · Cited by 28

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang, X., Li, H., Sheng, Y., He, B., Liu, Z., Li, W., Yu, S., Wang, J., Zhang, Y., Chen, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116071 · Cited by 29

The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells

Zhang, D., Zhang, J., & Liu, G.-T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.020 · Cited by 29

Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death

Tsuboi, K., Grzesiak, J. J., Bouvet, M., Hashimoto, M., Masliah, E., & Shults, C. W. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.001 · Cited by 29

Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis

Kamiyoshihara, T., Kojima, M., Uéda, K., Tashiro, M., & Shimotakahara, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.162 · Cited by 29

Hsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein

Miranda, H. V., Chegão, A., de Oliveira, M. S. D., Gomes, B. F., Enguita, F. J., & Outeiro, T. F. (2020) · The FASEB Journal · doi:10.1096/fj.201902936r · Cited by 28

Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus

Ishimaru, H., Uéda, K., Takahashi, A., & Maruyama, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00033-x · Cited by 30

Spatial patterns of α‐synuclein positive glial cytoplasmic inclusions in multiple system atrophy

Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2004) · Movement Disorders · doi:10.1002/mds.10637 · Cited by 29

Binding interactions of agents that alter α-synuclein aggregation

Sivanesam, K., Byrne, A., Bisaglia, M., Bubacco, L., & Andersen, N. H. (2015) · RSC Advances · doi:10.1039/c5ra00325c · Cited by 28

Early events in copper-ion catalyzed oxidation of α-synuclein

Tiwari, M. K., Leinisch, F., Sahin, C., Møller, I. M., Otzen, D. E., Davies, M. J., & Bjerrum, M. J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.559 · Cited by 28

Discovering network phenotype between genetic risk factors and disease status via diagnosis-aligned multi-modality regression method in Alzheimer’s disease

Wang, M., Hao, X., Huang, J., Shao, W., & Zhang, D. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty911 · Cited by 27

Heterogeneity in α‐synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease

Vaikath, N. N., Erskine, D., Morris, C. M., Majbour, N. K., Vekrellis, K., Li, J., & El‐Agnaf, O. M. A. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12531 · Cited by 28

Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons

Ramalingam, N., & Dettmer, U. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100271 · Cited by 29

In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129

Weston, L. J., Cook, Z. T., Stackhouse, T. L., Sal, M. K., Schultz, B. I., Tobias, Z. J. C., Osterberg, V. R., Brockway, N. L., Pizano, S., Glover, G., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105291 · Cited by 32

Identify connectome between genotypes and brain network phenotypes via deep self-reconstruction sparse canonical correlation analysis

Wang, M., Shao, W., Hao, X., Huang, S., & Zhang, D. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac074 · Cited by 28

Second Sphere Interactions in Amyloidogenic Diseases

Roy, M., Nath, A. K., Pal, I., & Dey, S. G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00941 · Cited by 29

Conformational Plasticity in α-Synuclein and How Crowded Environment Modulates It

Menon, S., & Mondal, J. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00982 · Cited by 27

GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with α-synuclein

Koob, A. O., Paulino, A., & Masliah, E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.034 · Cited by 28

A quantitative study of the pathological changes in white matter in multiple system atrophy

Armstrong, R. A., Cairns, N. J., & Lantos, P. L. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00759.x · Cited by 28

Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies

Chua, C. E. L., & Tang, B. L. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.03.002 · Cited by 28

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.

Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168

Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System

Irizarry, M. C., Kim, T., McNamara, M. J., Tanzi, R. E., George, J. M., Clayton, D. F., & Hyman, B. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00004 · Cited by 205

The Non-Amyloid-β Component of Alzheimer’s Disease Plaque Amyloid: Comparative Analysis Suggests a Normal Function as a Synaptic Plasticizer

George, J. M., & Clayton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_16 · Cited by 3

Properties of NACP/α-synuclein and its role in Alzheimer’s disease

Iwai, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00036-3 · Cited by 78

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease

Iwai, A., Masliah, E., Sundsmo, M. P., DeTeresa, R. M., Mallory, M. E., Salmon, D. P., & Saitoh, T. (1996) · Brain Research · doi:10.1016/0006-8993(96)00014-5 · Cited by 51